These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17632813)

  • 1. Heart-stopping news. The diabetes drug Avandia is under fire: what you should know. Interview by Avery Comarow.
    Psaty B
    US News World Rep; 2007 Jun; 142(20):64. PubMed ID: 17632813
    [No Abstract]   [Full Text] [Related]  

  • 2. Avandia in perspective.
    Comarow A
    US News World Rep; 2007 Oct; 143(11):71. PubMed ID: 17957906
    [No Abstract]   [Full Text] [Related]  

  • 3. The Avandia debate.
    Bloomgarden ZT
    Diabetes Care; 2007 Sep; 30(9):2401-8. PubMed ID: 17726191
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes drug safety update: Avandia and your heart.
    Johns Hopkins Med Lett Health After 50; 2010 Jun; 22(4):1-2, 7. PubMed ID: 20572316
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug safety. Heart attack risk overshadows a popular diabetes therapy.
    Couzin J
    Science; 2007 Jun; 316(5831):1550-1. PubMed ID: 17569830
    [No Abstract]   [Full Text] [Related]  

  • 6. Outlook on diabetes drug less than rosy. Early work suggests that rosiglitazone (Avandia) may not be best for the heart.
    Harv Heart Lett; 2007 Aug; 17(12):1-2. PubMed ID: 17717888
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA panel advises easing restrictions on rosiglitazone.
    Tucker ME
    BMJ; 2013 Jun; 346():f3769. PubMed ID: 23752055
    [No Abstract]   [Full Text] [Related]  

  • 8. Avandia and your heart.
    D'Arrigo T
    Diabetes Forecast; 2007 Jul; 60(8):16. PubMed ID: 17707991
    [No Abstract]   [Full Text] [Related]  

  • 9. Reviewer leaked Avandia study to drug firm.
    Vastag B
    Nature; 2008 Jan; 451(7178):509. PubMed ID: 18235464
    [No Abstract]   [Full Text] [Related]  

  • 10. Rosiglitazone, medical reversal, and back to basics for diabetes.
    Prasad V
    Am Fam Physician; 2014 Sep; 90(6):368, 370. PubMed ID: 25251229
    [No Abstract]   [Full Text] [Related]  

  • 11. In brief: rosiglitazone (Avandia) unbound.
    Med Lett Drugs Ther; 2014 Feb; 56(1435):12. PubMed ID: 24662977
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetes and heart failure: the role of thiazolidinediones in managing these partners in crime.
    Leier CV; Haas GJ
    J Am Coll Cardiol; 2007 Jul; 50(1):37-9. PubMed ID: 17601543
    [No Abstract]   [Full Text] [Related]  

  • 13. After Avandia, some seek split in drug approval and monitoring.
    Dolgin E
    Nat Med; 2010 Aug; 16(8):831. PubMed ID: 20689527
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug safety. Planned study of Avandia in doubt after FDA review.
    Kean S
    Science; 2010 Jul; 329(5990):375. PubMed ID: 20651123
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical inquiries. Do TZDs increase the risk of heart failure for patients with diabetes?
    Baskin S; Neher JO; Dodson S; Hoffman R
    J Fam Pract; 2005 Aug; 54(8):723-4. PubMed ID: 16061064
    [No Abstract]   [Full Text] [Related]  

  • 16. The rosiglitazone meta-analysis.
    McCullough PA; Lepor NE
    Rev Cardiovasc Med; 2007; 8(2):123-6. PubMed ID: 17603430
    [No Abstract]   [Full Text] [Related]  

  • 17. Critics press FDA to act on evidence of rosiglitazone's cardiac safety issues.
    Mitka M
    JAMA; 2010 Jun; 303(23):2341-2. PubMed ID: 20551399
    [No Abstract]   [Full Text] [Related]  

  • 18. GlaxoSmithKline denies it has settled thousands of lawsuits over rosiglitazone (Avandia).
    Tanne JH
    BMJ; 2010 Jun; 340():c3010. PubMed ID: 20530068
    [No Abstract]   [Full Text] [Related]  

  • 19. The record on rosiglitazone and the risk of myocardial infarction.
    Psaty BM; Furberg CD
    N Engl J Med; 2007 Jul; 357(1):67-9. PubMed ID: 17551162
    [No Abstract]   [Full Text] [Related]  

  • 20. Alternative medications exist for controversial diabetes drug. Patients concerned about rosiglitazone (Avandia) should talk with their doctors about other options.
    Heart Advis; 2010 Oct; 13(10):4. PubMed ID: 23189348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.